Optimization of extraction technology of the Anemone raddeana polysaccharides (ARP) by orthogonal test design and evaluation of its anti-tumor activity

Abstract In order to get high quality bioactive polysaccharides (ARP) from Anemone raddeana, an orthogonal experiment (L9(3)4) was applied to optimize the best extraction conditions. Extraction time, extraction temperature, number of extraction and water to raw material ratio were the main factors to influence the yield and purity of the extracted crude polysaccharides. The four factors chosen for the present investigation were based on the results of a single-factor test. The optimum extraction conditions were determined as follows: extraction time 1.5 h, temperature 80 °C, number 4 and water to raw material at 6. Under optimized conditions, the experimental yield 7.97 ± 0.27% agreed closely with the predicted yield. In vivo ARP at suitable dose is effective on Th1 cells, as associated with an enhancement of IgG2a and IgG2b levels. In vitro ARP significantly inhibited the proliferation of human hepatocellular carcinoma HEP-G2 and human intestinal cancer HCT-22 cells, indicating ARP could be a potential anti-cancer therapeutic agent.

[1]  S. Constant,et al.  Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. , 1997, Annual review of immunology.

[2]  J. Pezzuto,et al.  Plant-derived anticancer agents. , 1997, Biochemical pharmacology.

[3]  M. Ohnishi-Kameyama,et al.  Aralin, a new cytotoxic protein from Aralia elata, inducing apoptosis in human cancer cells. , 2003, Cancer letters.

[4]  Chun-ching Lin,et al.  Proliferative inhibition, cell-cycle dysregulation, and induction of apoptosis by ursolic acid in human non-small cell lung cancer A549 cells. , 2004, Life sciences.

[5]  V. Ooi,et al.  Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. , 2000, Current medicinal chemistry.

[6]  Xiao-Qiang Li,et al.  Structure of an anti-tumor polysaccharide from Angelica sinensis (Oliv.) Diels , 2006 .

[7]  Liu Da-you.  Progress in Studies on Chemical Constituents and Pharmacological Effect of Anemone Raddeana Regel , 2007 .

[8]  M. de Carli,et al.  Helper activity for immunoglobulin synthesis of T helper type 1 (Th1) and Th2 human T cell clones: the help of Th1 clones is limited by their cytolytic capacity , 1991, The Journal of experimental medicine.

[9]  Jicheng Liu,et al.  Haemolytic activities and adjuvant effect of Anemone raddeana saponins (ARS) on the immune responses to ovalbumin in mice. , 2008, International immunopharmacology.

[10]  T. K. Maiti,et al.  Anti-tumor and immunomodulating effects of Pleurotus ostreatus mycelia-derived proteoglycans. , 2006, International immunopharmacology.

[11]  T. Mosmann,et al.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones , 1989, The Journal of experimental medicine.

[12]  J. Kennedy,et al.  Structure, molecular size and antitumor activities of polysaccharides from Poria cocos mycelia produced in fermenter , 2007 .

[13]  Xia Li,et al.  Purification, structure and immunobiological activity of a new water-soluble polysaccharide from the mycelium of Polyporus albicans (Imaz.) Teng. , 2008, Bioresource technology.

[14]  N. Rowan,et al.  Medicinal Mushrooms and Cancer Therapy: translating a traditional practice into Western medicine , 2006, Perspectives in biology and medicine.

[15]  Jicheng Liu,et al.  Adjuvant effect of water-soluble polysaccharide (PAP) from the mycelium of Polyporus albicans on the immune responses to ovalbumin in mice. , 2008, Vaccine.

[16]  Wang Bx,et al.  Studies on pharmacological action of saponin of the root of Anemone raddeana. , 1985 .

[17]  F. Cui,et al.  Structural analysis of anti-tumor heteropolysaccharide GFPS1b from the cultured mycelia of Grifola frondosa GF9801. , 2007, Bioresource technology.

[18]  M. Gershwin,et al.  Mushrooms, Tumors, and Immunity: An Update , 2004, Experimental biology and medicine.